InflaRx (IFRX) Interest Coverage Ratio (2016 - 2026)
InflaRx's (IFRX) quarterly Interest Coverage Ratio came in at 481.53 in Q2 2026, down 87.49% year-over-year from 3850.37 in Q2 2025, and down 1.07% quarter-over-quarter from 486.74 in Q1 2026.
Analysis
InflaRx (IFRX) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
InflaRx has disclosed Interest Coverage Ratio across 11 years of filings, most recently posting 481.53 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 87.49% year-over-year to 481.53; the TTM figure through Jun 2026 stood at 597.43 (down 79.06% YoY), while the FY2025 annual figure was 1229.88, down 52.08% from the prior year.
- Interest Coverage Ratio came in at 481.53 for Q2 2026 at InflaRx, down from 486.74 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3850.37 in Q2 2025 to a low of 136.77 in Q2 2022.
- Average Interest Coverage Ratio over 5 years is 1643.96, with a median of 1511.86 recorded in 2024.
- Year-over-year, Interest Coverage Ratio slumped 97.02% in 2022 and surged 1326.41% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 712.44 in 2022, then surged by 76.92% to 1260.47 in 2023, then surged by 103.61% to 2566.39 in 2024, then plunged by 71.27% to 737.39 in 2025, then plunged by 34.7% to 481.53 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 481.53 in Q2 2026, 486.74 in Q1 2026, and 737.39 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | -481.53 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 481.53 |
| Mar 31, 2026 | 486.74 |
| Dec 31, 2025 | 737.39 |
| Sep 30, 2025 | 660.00 |
| Jun 30, 2025 | 3,850.37 |
| Mar 31, 2025 | 3,182.85 |
| Dec 31, 2024 | 2,566.39 |
| Sep 30, 2024 | 3,052.47 |
| Jun 30, 2024 | 1,763.25 |
| Mar 31, 2024 | 2,696.18 |
| Dec 31, 2023 | 1,260.47 |
| Sep 30, 2023 | 2,277.08 |
| Jun 30, 2023 | 1,950.94 |
| Mar 31, 2023 | 1,916.58 |
| Dec 31, 2022 | 712.44 |
| Sep 30, 2022 | 1,255.55 |
| Jun 30, 2022 | 136.77 |
| Mar 31, 2022 | 604.34 |
| Dec 31, 2021 | 1,923.16 |
| Sep 30, 2021 | 1,336.48 |